We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
27 Oct 2021 - 29 Oct 2021

DCN Diagnostics and Asahi Kasei Fibers Launch Market Collaboration

By LabMedica International staff writers
Posted on 30 Jul 2013
Print article
DCN Diagnostics (Carlsbad, CA, USA) and Asahi Kasei Fibers Corp. (AKFC; Osaka, Japan) will collaborate on a new colored nanoparticle designed to increase sensitivity in rapid assays. The new partnership will be based around AKFC's patented high-performance cellulose nanobead product, NanoAct. NanoAct represents a major step forward in visual labels for use in lateral flow and other rapid assays.

Utilizing cellulose technology matured and advanced for more than 80 years, Asahi Kasei developed patented and innovative colored nanobeads, NanoAct. Using the multicolored nanobeads as labels for lateral flow immunoassays, increased sensitivity, and faster test time is expected. NanoAct also has dispersion stability and does not require surfactants for aggregation control.

Consisting of a range of high intensity colored beads NanoAct can be multiplexed, generate higher sensitivity, lower CV's, and improved stability over many existing visual labels such as colloidal gold. This enables the application of lateral flow assays in demanding field assays for emerging infectious disease, consumer applications, biothreat detection, and biomarker testing.

DCN is a supplier of assay development, training, and consulting services to lateral flow assay developers and manufacturers. The company will be AKFC's distribution partner in North America and will be their preferred provider of Original Equipment Manufacturer (OEM) services to NanoAct users worldwide, except Japan.

"This new product line is a great addition to DCN's existing portfolio of high performance reagents and materials for lateral flow test producers," said DCN's president, Brendan O'Farrell. "This new product line is a great addition to DCN's existing portfolio of high performance reagents and materials for lateral flow test producers."

DCN and AKFC will be showcasing NanoAct at the AACC conference in Houston, Texas (USA), on July 28–August 1, 2013.

Related Links:

DCN Diagnostics
Asahi Kasei Fibers Corp.



Gold Supplier
SARS-CoV-2 S-IgG Antibody Assay
Lumipulse G SARS-CoV-2 S-IgG
New
Lateral Flow Test Cassette Reader
Quantum Blue III
New
Gold Supplier
Lactate Dehydrogenase (LDH) Assay
LDH 21 FS
New
Cardiovascular Disease POC Analyzer
cobas h 232 POC System

Print article

Channels

Hematology

view channel
Image: Psoriatic plaques, showing a silvery center surrounded by a reddened border (Photo courtesy of Jane Bianchi, BA)

Hematological Parameters Compared in Psoriasis Patients

Psoriasis is a chronic, immune-mediated disorder that can involve the skin and/or joints. Four clinical types of psoriasis are currently recognized: psoriasis vulgaris (PsV), pustular psoriasis (PP), erythrodermic... Read more

Microbiology

view channel
Illustration

Sysmex Inostics Launches New Ultra-Sensitive Leukemia Blood Test for Early Detection of Cancer Cells Following Initial Therapy

Sysmex Inostics (Baltimore, MD, USA) has developed a new CLIA-validated liquid biopsy test for the detection of Minimal Residual Disease (MRD) in Acute Myeloid Leukemia (AML) to better help in the fight... Read more

Technology

view channel
Image: QIAreach QuantiFERON-TB (Photo courtesy of QIAGEN N.V.)

Qiagen Launches Novel Tuberculosis Blood Test That Marks Quantum Leap from Traditional TB Skin Test

QIAGEN N.V. (Venlo, Netherlands) has announced the launch and CE marking of QIAreach QuantiFERON-TB test for tuberculosis (TB) infection, in order to help achieve global TB elimination targets by increasing... Read more

Industry

view channel
Image: GastroPanel Quick Test (Photo courtesy of Biohit Healthcare)

Biohit’s Innovative GastroPanel Quick Test Receives CE Mark

Biohit Healthcare’s (Helsinki, Finland) GastroPanel Quick Test, the latest innovation in its unique GastroPanel product family, is now CE marked. The GastroPanel Quick Test is intended for diagnosing... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.